Mizuho Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mizuho Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$76K	Sell	626 -368	-37%	-$49.6K	0.02%	528
2016 Q2	$140K	Buy	994 +630	+173%	+$92.9K	0.03%	444
2016 Q1	$63K	Sell	364 -453	-55%	-$56.4K	0.02%	476
2015 Q4	$115K	Buy	817 +182	+29%	+$25.2K	0.02%	471
2015 Q3	$84K	Buy	635 +130	+26%	+$22.4K	0.02%	503
2015 Q2	$89K	Buy	505 +141	+39%	+$25.3K	0.02%	454
2015 Q1	$63K	Buy	364 +129	+55%	+$22.1K	0.02%	476
2014 Q4	$38K	Buy	+235	New	+$39K	0.01%	509

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Mizuho Asset Management's JAZZ Position: Q3 2016 in Review

Mizuho Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 37% in Q3 2016, selling an estimated $49.6K and leaving 626 shares worth $76K. The position accounts for 0.02% of the portfolio, ranked #528.

Mizuho Asset Management first reported a position in JAZZ in Q4 2014 and has held it in 8 quarters since. The position peaked at $140K in Q2 2016. 326 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Mizuho Asset Management held 626 shares of Jazz Pharmaceuticals worth $76K as of Q3 2016.
Mizuho Asset Management sold 368 Jazz Pharmaceuticals shares in Q3 2016, an estimated $49.6K.
Jazz Pharmaceuticals made up 0.02% of Mizuho Asset Management's portfolio in Q3 2016, its #528 holding.
Mizuho Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 8 quarters since.
Mizuho Asset Management's Jazz Pharmaceuticals position peaked at $140K in Q2 2016.
326 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.